Last reviewed 2026-04-20 · How we verify

Pf-07923568 (pf-07923568)

At a glance

Approved indications

• Multiple Myeloma
• Lymphoma
• Leukemia

Common side effects

No common side effects on file.

Drug interactions

• Warfarin
• Aspirin
• Pentobarbital
• Phenobarbital
• Rivaroxaban
• Apixaban
• Dabigatran
• Clopidogrel
• Ticagrelor
• Prasugrel
• Cilostazol
• Dipyridamole

Key clinical trials

• A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV (PHASE1)
• A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants. (PHASE1)
• A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants. (PHASE1)
• A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants. (PHASE1)
• A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants. (PHASE1)
• A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Pf-07923568 CI brief — competitive landscape report
• Pf-07923568 updates RSS · CI watch RSS
• Pfizer portfolio CI